Rankings
▼
Calendar
NMRA Q4 2020 Earnings — Neumora Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
NMRA
Neumora Therapeutics, Inc. Common Stock
$586M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$20M
EPS (Diluted)
$-0.13
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$18M
Stock-Based Comp.
$824,000
Balance Sheet
Total Assets
$198M
Total Liabilities
$292M
Stockholders' Equity
-$94M
Cash & Equivalents
$192M
← FY 2020
All Quarters
Q1 2021 →
